Guidance
Evidence-based recommendations on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia. This involves positioning a temporary implant in the urethra to increase the flow of urine.
NICE has also published a medtech innovation briefing on iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia.
Is this guidance up to date?
Next review: September 2025
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance.
This guidance replaces NICE interventional procedures guidance on prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG641).